Biosimilars Market Entry Strategies - For Pharma Companies, Biosimilars Offer a Relatively Low Risk Growth Strategy

DALLAS, December 26, 2011 /PRNewswire/ --

ReportsnReports adds new market research report 'Biosimilars : Market Entry Strategies' to its store. This report provides an analysis of strategies employed by the top 50 pharma companies that are active or plan to enter the biosimilars sector in the future, together with an analysis of biosimilar deal trends among the top 50 pharma companies.

• Of the companies analyzed, each of the eight generics companies ranked among the top 50 pharma companies have an active interest in biosimilars, reflecting the fact that such products have the opportunity to increase the profit margin of generics companies.
• Many innovative pharma companies have also entered the biosimilars arena with further companies such as Boehringer Ingelheim showing signs of interest.
• However, a number of companies such as AstraZeneca, Bayer, and Roche have stated that they have no plans to enter the biosimilars market, instead maintaining their innovative focus.

Study Comprehensive Table of Contents and Request a Sample for the report @  http://www.reportsnreports.com/reports/144201-biosimilars-market-entry-strategies.html

With sales for the top 50 pharma companies forecast to decline by 1.6% during 2010-16, many leading drugmakers are looking to expand into markets which offer long-term growth, limited competition, and are relatively low risk. Biosimilars is one such area, which has attracted both innovative biologics players and generics players alike.

Features and benefits

• Insight into why pharma are tapping into the biosimilars market
• Analysis of biosimilar deal trends among the top 50 pharma companies
• Insight into the top 50 pharma companies active in biosimilars
• Review of the top 50 pharma companies that plan to enter the biosimilars market in the near future
• Summary of the top 50 pharma companies plan to avoid biosimilars

Your key questions answered

• Understand how and why different corporate pharma companies are targeting biosimilars
• Examine why some companies have opted not to enter this sector

Inquire Before Buying or get your copy of the report on Biosimilars Market Entry Strategies.

Find other newly published market research reports @ http://www.reportsnreports.com/latest-market-research.aspx.

About Us:

ReportsnReports.com is an online market research library of 135,000+ reports and in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Visit http://www.reportsnreports.com/ for more details.

Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
[email protected]
Visit our Market Research Blog @ http://www.reportsnreportsblog.com/

SOURCE ReportsnReports